How Normal is a 'Normal' Heart in Fetuses and Infants with Down Syndrome?

Emmeline Calkoen1, Bauke Adriaanse, Monique Haak

  • 1Department of Anatomy and Embryology, Leiden University Medical Center, Leiden, The Netherlands.

Insights

Hearts in fetuses with Down syndrome (DS) show differences even without apparent defects. Studies reveal a larger membranous septum, shorter ventricular septum, and valve dysplasia in DS hearts compared to controls.

Area of Science:

  • Cardiology
  • Developmental Biology
  • Genetics

Background:

  • Down syndrome (DS) is associated with congenital heart disease in 44-56% of fetuses.
  • Cardiac differences exist in DS fetuses even without overt structural heart defects.
  • Atrioventricular (AV) septum and valve morphology in DS require further investigation.

Purpose of the Study:

  • To compare the atrioventricular (AV) septum and valves in fetuses with Down syndrome (DS) and controls.
  • To investigate cardiac differences in DS fetuses with and without atrioventricular septal defects (AVSD).

Main Methods:

  • Histological examination of ventricular septum, membranous septum, and AV valves in 15 DS no-AVSD, 8 DS AVSD, and 34 control hearts.
  • Ultrasound measurement of ventricular septum length in fetal and infant hearts (DS and controls).

Main Results:

  • The membranous septum was 3 times larger in DS fetuses without AVSD compared to controls.
  • Valve dysplasia was observed in 64% of DS hearts without AVSD.
  • The ventricular septum was shorter in DS hearts (with and without AVSD) than in controls.

Conclusions:

  • Hearts in DS fetuses without AVSD exhibit significant structural differences.
  • These differences include a larger membranous septum, shorter ventricular septum, and AV valve dysplasia.
  • DS hearts, even without apparent septal defects, are not anatomically normal.
Abstract

Related Concept Videos

Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart...
3.8K
Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
4.7K
Meiosis vs. Mitosis02:57

Meiosis vs. Mitosis

Cell division is necessary for growth and reproduction in organisms. Mitosis aids cell growth and development by dividing somatic cells. In contrast, meiosis causes the division of germ cells and plays an essential role in sexual reproduction. Due to their unique functional requirements, mitosis and meiosis differ from each other in multiple aspects.
Before the start of mitosis and meiosis I, the cell synthesizes DNA, resulting in two homologous copies of each chromosome. DNA synthesis is...
74.5K
Meiosis I01:49

Meiosis I

Meiosis is a carefully orchestrated set of cell divisions, the goal of which—in humans—is to produce haploid sperm or eggs, each containing half the number of chromosomes present in somatic cells elsewhere in the body. Meiosis I is the first such division, and involves several key steps, among them: condensation of replicated chromosomes in diploid cells; the pairing of homologous chromosomes and their exchange of information; and finally, the separation of homologous chromosomes by...
222.1K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.6K
Development of Blood Vessels01:07

Development of Blood Vessels

The development of the vascular system in a fetus is a complex and intricate process that begins as early as 15 to 16 days post-conception. This process starts outside the embryo, specifically in the mesoderm of the yolk sac, chorion, and connecting stalk. Approximately two days later, the formation of blood vessels occurs within the embryo itself.
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...
1.9K